Clincosm LogoSign in Get a demo

nonalcoholic steatohepatitis (nash)

Showing 1 - 25 of 36
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH) Trial in Hialeah Gardens

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Metabolic Dysfunction-associated Steatohepatitis (MASH)
  • Hialeah Gardens, Florida
    Site #430
Nov 1, 2023

Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC), Systemic Sclerosis (SSc) Trial in Tel Aviv (CM-101,

Completed
  • Nonalcoholic Steatohepatitis (NASH)
  • +2 more
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Sep 7, 2023

Nonalcoholic Steatohepatitis (NASH) Trial in Taiwan (ADI-PEG20, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Kaohsiung, Taiwan
  • +4 more
Apr 24, 2023

Nonalcoholic Steatohepatitis (NASH) Trial (ASC41 2 mg, ASC41 4 mg, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • ASC41 2 mg
  • +2 more
  • (no location specified)
Jan 30, 2023

Nonalcoholic Steatohepatitis (NASH) Trial in Guangzhou (ZSP1601, Placebo)

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Guangzhou, China
    NanFang Hospital
Jan 10, 2023

Nonalcoholic Steatohepatitis (NASH) Trial in Miami Lakes, Tulsa, Waco (HTD1801, Placebo)

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Miami Lakes, Florida
  • +2 more
Jan 13, 2023

Nonalcoholic Steatohepatitis (NASH), Fibrosis, Liver, NAFLD Trial (Rencofilstat, Placebo)

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • +2 more
  • Huntsville, Alabama
  • +40 more
Dec 7, 2022

Nonalcoholic Steatohepatitis (NASH) Trial in United States (BOS-580, Placebo)

Active, not recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Birmingham, Alabama
  • +11 more
Dec 4, 2022

Nonalcoholic Steatohepatitis (NASH) Trial (CS0159 (Linafexor))

Not yet recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • CS0159 (Linafexor)
  • (no location specified)
Nov 14, 2022

Nonalcoholic Steatohepatitis

Recruiting
  • Nonalcoholic Fatty Liver Disease (NAFLD)
  • Nonalcoholic Steatohepatitis (NASH)
  • Acoustic radiation force impulse (ARFI), magnetic resonance elastography (MRE)
  • Montréal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal
Nov 11, 2022

Nonalcoholic Steatohepatitis (NASH) Trial in United States (Miricorilant 150 mg, Miricorilant 100 mg)

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Miricorilant 150 mg
  • +2 more
  • Chandler, Arizona
  • +9 more
Oct 27, 2022

Nonalcoholic Steatohepatitis (NASH) Trial in Gent (ORMD-0801 QD, ORMD-0801 BD)

Completed
  • Nonalcoholic Steatohepatitis (NASH)
  • ORMD-0801 QD
  • ORMD-0801 BD
  • Gent, Belgium
    Universitaire Ziekenhuis Gent
Sep 15, 2022

Nonalcoholic Steatohepatitis (NASH) Trial in United States (Miricorilant, Placebo)

Terminated
Has Results
  • Nonalcoholic Steatohepatitis (NASH)
  • Chandler, Arizona
  • +14 more
Aug 10, 2022

Nonalcoholic Steatohepatitis (NASH) Trial in Worldwide (BMS-986263, Placebo)

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • Phoenix, Arizona
  • +113 more
Aug 22, 2022

Nonalcoholic Steatohepatitis (NASH) Trial in United States (LPCN 1144 Formulation A, LPCN 1144 Formulation B, Placebo)

Completed
  • Nonalcoholic Steatohepatitis (NASH)
  • LPCN 1144 Formulation A
  • +2 more
  • El Cajon, California
  • +18 more
Aug 1, 2022

Pharmacokinetics of Miricorilant in Presumed Nonalcoholic

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • MRI-PDFF
  • Chandler, Arizona
  • +7 more
Apr 8, 2022

Nonalcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver Disease (NAFLD) Trial in New Zealand, United States (SEL, FIR,

Completed
Has Results
  • Nonalcoholic Steatohepatitis (NASH)
  • Nonalcoholic Fatty Liver Disease (NAFLD)
  • Chandler, Arizona
  • +12 more
Mar 7, 2022

Nonalcoholic Steatohepatitis (NASH), Overweight or Obesity Trial in Chula Vista, Montclair (FT-4101, FT-4101 , Deuterated Water)

Terminated
  • Nonalcoholic Steatohepatitis (NASH)
  • Overweight or Obesity
  • Chula Vista, California
  • +1 more
Mar 14, 2022

Multi-Organ Metabolism and Perfusion in NAFLD by Total Body

Recruiting
  • Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Nonalcoholic Steatohepatitis (NASH)
  • Positron Emission Tomography (PET) on EXPLORER
  • +3 more
  • Sacramento, California
    UC Davis
Dec 16, 2021

Nonalcoholic Steatohepatitis (NASH) Trial in Cairo (Vitamin E, Ursodeoxycholic acid, Pentoxifylline)

Completed
  • Nonalcoholic Steatohepatitis (NASH)
  • Vitamin E
  • +2 more
  • Cairo, Egypt
    Hepatology, gastroenterology and infectious diseases department
Jul 15, 2021

Nonalcoholic Steatohepatitis (NASH) Trial in Beijing (XZP-5610 Tablet (for Part A), Placebo to match XZP-5610 Tablet (for Part

Recruiting
  • Nonalcoholic Steatohepatitis (NASH)
  • XZP-5610 Tablet (for Part A)
  • +5 more
  • Beijing, China
    Peking University Third Hospital
Jun 2, 2021

Nonalcoholic Steatohepatitis (NASH) Trial in Shanghai (HEC96719)

Completed
  • Nonalcoholic Steatohepatitis (NASH)
  • Shanghai, Shanghai, China
    The Shanghai xuhui district central hospital
May 6, 2021

Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis (PSC) Trial in New Zealand, United States (Cilofexor)

Completed
Has Results
  • Nonalcoholic Steatohepatitis (NASH)
  • Primary Sclerosing Cholangitis (PSC)
  • Miami, Florida
  • +4 more
Dec 14, 2020

Nonalcoholic Steatohepatitis (NASH) Trial in Shanghai (HEC96719 tablets, Placebo tablet)

Completed
  • Nonalcoholic Steatohepatitis (NASH)
  • HEC96719 tablets
  • Placebo tablet
  • Shanghai, Shanghai, China
    The Shanghai xuhui district central hospital
Dec 23, 2020

Nonalcoholic Steatohepatitis (NASH) Trial in United States (Firsocostat, Fenofibrate)

Completed
Has Results
  • Nonalcoholic Steatohepatitis (NASH)
  • Tustin, California
  • +4 more
Nov 23, 2020